Cargando…

Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer

SIMPLE SUMMARY: Stereotactic body radiotherapy (SBRT) is an effective modality for early-stage lung cancer. However, limited information is currently available on histological differences in recurrence patterns after SBRT for early-stage lung cancer. Therefore, the present study compared recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Kita, Nozomi, Tomita, Natsuo, Takaoka, Taiki, Sudo, Shuou, Tsuzuki, Yusuke, Okazaki, Dai, Niwa, Masanari, Torii, Akira, Takano, Seiya, Niimi, Akio, Hiwatashi, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913504/
https://www.ncbi.nlm.nih.gov/pubmed/36765844
http://dx.doi.org/10.3390/cancers15030887
_version_ 1784885443834150912
author Kita, Nozomi
Tomita, Natsuo
Takaoka, Taiki
Sudo, Shuou
Tsuzuki, Yusuke
Okazaki, Dai
Niwa, Masanari
Torii, Akira
Takano, Seiya
Niimi, Akio
Hiwatashi, Akio
author_facet Kita, Nozomi
Tomita, Natsuo
Takaoka, Taiki
Sudo, Shuou
Tsuzuki, Yusuke
Okazaki, Dai
Niwa, Masanari
Torii, Akira
Takano, Seiya
Niimi, Akio
Hiwatashi, Akio
author_sort Kita, Nozomi
collection PubMed
description SIMPLE SUMMARY: Stereotactic body radiotherapy (SBRT) is an effective modality for early-stage lung cancer. However, limited information is currently available on histological differences in recurrence patterns after SBRT for early-stage lung cancer. Therefore, the present study compared recurrence patterns between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) after SBRT. Among the 204 patients included in the analysis, 138 and 66 were in the ADC and SCC groups, respectively. The local recurrence (LR) rate was significantly higher in the SCC group than in the ADC group, while lymph node metastasis and distant metastasis rates were not associated with the histological type. Tumor diameter and histological type correlated with LR in multivariate analyses. The present results suggest that the risk of LR after SBRT is higher for SCC than for ADC. ABSTRACT: We compared recurrence patterns between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) after stereotactic body radiotherapy (SBRT) for early-stage lung cancer. Patients with ADC and SCC histology, who were treated with SBRT for clinical stage IA1-IIA lung cancer at our institution, were included in the analysis. The rates of disease-free survival (DFS), overall survival (OS), local recurrence (LR), lymph node metastasis (LNM), and distant metastasis (DM) were calculated using the Kaplan–Meier method or the cumulative incidence function. Among the 204 patients analyzed, 138 and 66 were in the ADC and SCC groups, respectively. The median follow-up period was 60 months. The five-year DFS and OS rates were 57% vs. 41% and 69% vs. 48% in the ADC and SCC groups, respectively (p = 0.015 and 0.019, respectively). In the multivariate analysis, the histological type was not associated with DFS or OS. Five-year LR, LNM, and DM rates were 10% vs. 24%, 12% vs. 20%, and 25% vs. 27% in the ADC and SCC groups, respectively (p = 0.0067, 0.074, and 0.67, respectively). The multivariate analysis identified the histological type of SCC as an independent factor for LR (hazard ratio, 2.41; 95% confidence interval, 1.21–4.77; p = 0.012). The present results suggest that the risk of LR after SBRT is higher for SCC than for ADC.
format Online
Article
Text
id pubmed-9913504
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99135042023-02-11 Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer Kita, Nozomi Tomita, Natsuo Takaoka, Taiki Sudo, Shuou Tsuzuki, Yusuke Okazaki, Dai Niwa, Masanari Torii, Akira Takano, Seiya Niimi, Akio Hiwatashi, Akio Cancers (Basel) Article SIMPLE SUMMARY: Stereotactic body radiotherapy (SBRT) is an effective modality for early-stage lung cancer. However, limited information is currently available on histological differences in recurrence patterns after SBRT for early-stage lung cancer. Therefore, the present study compared recurrence patterns between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) after SBRT. Among the 204 patients included in the analysis, 138 and 66 were in the ADC and SCC groups, respectively. The local recurrence (LR) rate was significantly higher in the SCC group than in the ADC group, while lymph node metastasis and distant metastasis rates were not associated with the histological type. Tumor diameter and histological type correlated with LR in multivariate analyses. The present results suggest that the risk of LR after SBRT is higher for SCC than for ADC. ABSTRACT: We compared recurrence patterns between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) after stereotactic body radiotherapy (SBRT) for early-stage lung cancer. Patients with ADC and SCC histology, who were treated with SBRT for clinical stage IA1-IIA lung cancer at our institution, were included in the analysis. The rates of disease-free survival (DFS), overall survival (OS), local recurrence (LR), lymph node metastasis (LNM), and distant metastasis (DM) were calculated using the Kaplan–Meier method or the cumulative incidence function. Among the 204 patients analyzed, 138 and 66 were in the ADC and SCC groups, respectively. The median follow-up period was 60 months. The five-year DFS and OS rates were 57% vs. 41% and 69% vs. 48% in the ADC and SCC groups, respectively (p = 0.015 and 0.019, respectively). In the multivariate analysis, the histological type was not associated with DFS or OS. Five-year LR, LNM, and DM rates were 10% vs. 24%, 12% vs. 20%, and 25% vs. 27% in the ADC and SCC groups, respectively (p = 0.0067, 0.074, and 0.67, respectively). The multivariate analysis identified the histological type of SCC as an independent factor for LR (hazard ratio, 2.41; 95% confidence interval, 1.21–4.77; p = 0.012). The present results suggest that the risk of LR after SBRT is higher for SCC than for ADC. MDPI 2023-01-31 /pmc/articles/PMC9913504/ /pubmed/36765844 http://dx.doi.org/10.3390/cancers15030887 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kita, Nozomi
Tomita, Natsuo
Takaoka, Taiki
Sudo, Shuou
Tsuzuki, Yusuke
Okazaki, Dai
Niwa, Masanari
Torii, Akira
Takano, Seiya
Niimi, Akio
Hiwatashi, Akio
Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer
title Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer
title_full Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer
title_fullStr Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer
title_full_unstemmed Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer
title_short Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer
title_sort comparison of recurrence patterns between adenocarcinoma and squamous cell carcinoma after stereotactic body radiotherapy for early-stage lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913504/
https://www.ncbi.nlm.nih.gov/pubmed/36765844
http://dx.doi.org/10.3390/cancers15030887
work_keys_str_mv AT kitanozomi comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT tomitanatsuo comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT takaokataiki comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT sudoshuou comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT tsuzukiyusuke comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT okazakidai comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT niwamasanari comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT toriiakira comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT takanoseiya comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT niimiakio comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer
AT hiwatashiakio comparisonofrecurrencepatternsbetweenadenocarcinomaandsquamouscellcarcinomaafterstereotacticbodyradiotherapyforearlystagelungcancer